Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.
about
Diet and Alzheimer’s disease risk factors or prevention: the current evidenceNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesNon-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studiesDoes neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytesThe role of inflammasome in Alzheimer's diseaseInflammatory process in Alzheimer's DiseaseNonsteroidal anti-inflammatory drugs are associated with increased neuritic plaquesIntranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsNO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.Lost in translation: epidemiology, risk, and Alzheimer disease.Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice.Can peripheral leukocytes be used as Alzheimer's disease biomarkers?The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onsetTracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.Current treatment and recent clinical research in Alzheimer's diseaseAdaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesAcupuncture at the Taixi (KI3) acupoint activates cerebral neurons in elderly patients with mild cognitive impairment.Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseA critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease.Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment.Histamine-2 receptor antagonist use and incident dementia in an older cohortRheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease.Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's diseaseProspects for delaying the rising tide of worldwide, late-life dementiasCRP gene variation affects early development of Alzheimer's disease-related plaques.Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.Decreased C-reactive protein levels in Alzheimer diseaseEffects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial.Association of incident dementia with hospitalizationsBreaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathologyBridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk ReductionExtensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyAccelerated failure time models for semi-competing risks data in the presence of complex censoring.NSAID Use and Incident Cognitive Impairment in a Population-based Cohort.Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.Cognitive dysfunction with aging and the role of inflammationNeuroinflammatory phenotype in early Alzheimer's disease.
P2860
Q22241476-DDD2E236-7BB9-4B63-ABD0-1A12792BDABEQ24235107-9B6C94A4-785F-4EB1-9AAE-87599BB96F5EQ24236199-ED1D6A0A-C0CB-4FFC-9151-D4DD690238BFQ26797413-E6274930-63DE-4B89-A4B3-D4AC9FAF276BQ26996822-706362E2-EA7A-4C62-974B-A16A6EB3BB16Q27500412-A1250F4E-575C-4D18-B560-4E35707DDC13Q28476681-0D18A0D3-7E7E-419E-98F6-EB00BD6988E0Q30362847-EE5BF94D-4ECB-4A8F-A08B-13A31B8B64DFQ30814231-A4503333-132B-47F9-8BE3-D9A902D5BA9FQ33496256-3D6DF8D1-FFC1-4B62-9782-63F4E594DEAAQ33591187-60E8580B-D8F5-41E9-BA03-5C62EF5F6B29Q33678988-E8E598A3-1AC4-47CE-B411-49427D8D5987Q33689076-870C49EB-A333-4E21-B198-E543472EC636Q33873941-2BA35172-2A31-4BC5-A73E-DE9270952399Q33904501-EF41D10E-6113-4C4B-B41C-323267783382Q34067487-73CA3B89-CD7C-47ED-8C76-DCC5CF0AB8A1Q34071942-FED4B7D6-1C73-49AC-9F1A-209B60920095Q34095385-84931BD4-7DA7-40C3-AB72-8D29423A3EF3Q34110934-F3CB9054-53A2-48FA-838C-B7E8D66540E9Q34306241-BF7FBDA7-D872-47EB-BCCE-4629123D48DCQ34376103-4B91B0BE-1C66-4D8F-8724-CF1F67F3242AQ34505182-8EC4F1A5-A808-4E7A-BE7D-4EF463968C2CQ34507706-A46999C5-C9C8-413C-A123-D460F42EBEF7Q35047417-0C3E553D-8F11-492C-96AB-87AE182C496BQ35061264-CBD6C802-4C54-4D08-8133-D5DC5143BF25Q35167904-8E8F89C3-2478-4C16-A5A0-2F49203F766AQ35189789-0B00BEA6-6B63-4071-8C3D-DCDFA781B013Q35200584-8E13183E-B8D2-44A7-8073-934F5D307CDEQ35214415-903A1D9C-6B1D-4AF0-BEBE-E1EAF00FDF7AQ35482118-1A04C7D6-D9D4-43C3-8BB2-C5CD7B2D7842Q35523832-592E7DB5-F33F-4966-960C-BBC011706E2CQ35854471-0D60AEC7-5996-4A78-BDDE-6A94D1BD987EQ36018333-A24EB1D4-4153-4940-B52E-AC49DA88BA17Q36057021-1C89489D-CAE7-4FAD-BD08-A257F4D154F0Q36164195-4E967591-4EE5-4603-A663-BDF85D0A5172Q36342349-5B2412DC-1A84-49FB-9789-FA443C990807Q36348370-53E4C736-314E-4C8D-A943-3E9D4C1F4F92Q36370466-B028561A-7964-42AE-9582-EE46846CA530Q36443732-EDE50E78-9FA2-4AAB-A166-C5A76E00F888Q36629135-7CBFF194-B474-4268-9F62-F88E2C8C38C5
P2860
Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of dementia and AD with p ...... lderly community-based cohort.
@en
Risk of dementia and AD with p ...... lderly community-based cohort.
@nl
type
label
Risk of dementia and AD with p ...... lderly community-based cohort.
@en
Risk of dementia and AD with p ...... lderly community-based cohort.
@nl
prefLabel
Risk of dementia and AD with p ...... lderly community-based cohort.
@en
Risk of dementia and AD with p ...... lderly community-based cohort.
@nl
P2093
P2860
P1433
P1476
Risk of dementia and AD with p ...... elderly community-based cohort
@en
P2093
E B Larson
J C S Breitner
S J P A Haneuse
P2860
P304
P356
10.1212/WNL.0B013E3181A18691
P407
P577
2009-04-22T00:00:00Z